Compare Johnson & Johnson (JNJ) vs YieldMax NVDA Option Income Strategy ETF (NVDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs YieldMax NVDA Option Income Strategy ETF — how do they compare? Johnson & Johnson trades at $261.44 (market cap $618.09B), while YieldMax NVDA Option Income Strategy ETF trades at $12.57 (market cap $1.45B). The key difference: Johnson & Johnson is far larger — about 426.3× YieldMax NVDA Option Income Strategy ETF's market cap, and Johnson & Johnson pays a 2.09% dividend while YieldMax NVDA Option Income Strategy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and YieldMax NVDA Option Income Strategy ETF for 43 Days on average.
| JNJ | NVDY | |
|---|---|---|
Market Cap | $618.09B | $1.45B |
Volume | 6,050,983 | 1,943,739 |
Sector | Health | Income / Options Overlay |
52-Week High | $278.43 | $17.21 |
52-Week Low | $186.00 | $11.58 |
Typical Hold Time | 129 Days | 43 Days |
Enterprise Value | $646.37B | — |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.
JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.
NVDY, the YieldMax NVDA Option Income Strategy ETF, trades at $12.62, down 3.0% today, amid a bearish technical signal. The fund generates income via options on NVIDIA stock, with recent weekly dividends averaging around $0.10. However, technical indicators show selling pressure, with moving averages and ADX signaling bearish momentum, while oscillators remain neutral. Recent news highlights concerns over NAV erosion and capped upside despite high distribution yields.
The outlook is cautious due to structural limitations on capital appreciation and reliance on NVIDIA's volatility for income. Risks include potential NAV decay from the options strategy and sensitivity to changes in implied volatility. Analyst sentiment is neutral to bearish, with downgrades citing diminished income potential. Investors seeking NVIDIA exposure may find direct ownership more favorable for growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About YieldMax NVDA Option Income Strategy ETF
NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →
